Evidence map›Paper›PMID 33195351›Full record

ArticleFrontiers in medicine2020

Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab.

Mouhamed Yazan Abou-Ismail, Yasmin Arafah, Pingfu Fu, Shufen Cao, Alvin H Schmaier, Lalitha Nayak

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mouhamed Yazan Abou-IsmailCase Western Reserve University, Cleveland, OH, United States.
Yasmin ArafahCase Western Reserve University, Cleveland, OH, United States.
Pingfu FuCase Western Reserve University, Cleveland, OH, United States.
Shufen CaoCase Western Reserve University, Cleveland, OH, United States.
Alvin H SchmaierCase Western Reserve University, Cleveland, OH, United States.
Lalitha NayakCase Western Reserve University, Cleveland, OH, United States.
Case Western Reserve University · USUniversity Hospitals of Cleveland · US

Funding

Contact Pathway Activation on Vascular DevicesR01HL144113 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HINDS, MONICA T, MCCARTY, OWEN J · 2018 to 2025
$6.0M
Novel approaches to improve prediction of cancer-associated thrombosisU01HL143402 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI KHORANA, ALOK A, MCCRAE, KEITH R. · 2018 to 2022
$4.7M
Kruppel-Like Factor 2 Counters Vascular and Immunologic Dysfunction in Child Cerebral MalariaR01AI130131 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 2017 to 2021
$3.0M
MRP-14, CD36 and ThrombosisR01HL126645 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI SIMON, DANIEL I · 2016 to 2019
$2.0M
Role of myeloid KLF2 in antiphospholipid antibody-mediated thrombosisR01HL142647 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI NAYAK, LALITHA · 2018 to 2021
$1.9M
Ponatinib Induces Vascular Events in CML-Mechanisms and CorrectionR21CA223301 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI SCHMAIER, ALVIN H · 2019 to 2020
$397k
NCI NIH HHS R21 CA223301NHLBI NIH HHS R01 HL126645NHLBI NIH HHS R01 HL142647NHLBI NIH HHS R01 HL144113NHLBI NIH HHS U01 HL143402NIAID NIH HHS R01 AI130131
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cyclophosphamiderelapserituximabthrombotic thrombocytopenic purpuratreatment

Identifiers

PMID33195351
PMCPMC7657267
OpenAlexW3097798376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.